An NK cell population lacking FcRgamma is expanded in chronically infected HIV patients

Jingling Zhou, Fathiah S Amran, Marit Kramski, Thomas A Angelovich, Julian Elliott, Anna Clare Hearps, Patricia Price, Anthony Jaworowski

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Abstract

We previously demonstrated that NK cells from HIV-infected individuals have elevated expression of activation markers, spontaneously degranulate ex vivo, and decrease expression of a signal-transducing protein for NK-activating receptors, FcR?. Importantly, these changes were maintained in virologically suppressed (VS) individuals receiving combination antiretroviral therapy (cART). In this study, we show that loss of FcR? is caused by the expansion of a novel subset of FcR?- CD56dim NK cells with an altered activation receptor repertoire and biological properties. In a cross-sectional study, FcR?- NK cells as a proportion of total CD56dim NK cells increased in cART-naive viremic HIV-infected individuals (median [interquartile range] = 25.9 [12.6- 56.1] compared with 3.80 [1.15-11.5] for HIV- controls, p <0.0001) and in VS HIV-infected individuals (22.7 [13.1-56.2] compared with 3.80 [1.15-11.5], p = 0.0004), with no difference between cART-naive and VS patients (p = 0.93). FcR?-NK cells expressed no NKp30 or NKp46. They showed greater Ab-dependent cellular cytotoxicity activity against rituximab-opsonized Raji cells and in a whole-blood assay measuring NK responses to overlapping HIV peptides, despite having reduced CD16 expression compared with conventional NK cells. Their prevalence correlated with CMV Ab titers in HIV- subjects but not in HIV,+ individuals, and with the inflammatory marker CXCL10 in both groups. The expansion of a subset of NK cells that lacks NKp30 and NKp46 to 90 of CD56dim NK cells in some VS HIV+ individuals may influence NK-mediated immunosurveillance in patients receiving cART. Copyright ? 2015 by The American Association of Immunologists, Inc.
Original languageEnglish
Pages (from-to)4688 - 4697
Number of pages10
JournalJournal of Immunology
Volume194
Issue number10
DOIs
Publication statusPublished - 2015

Cite this

Zhou, Jingling ; Amran, Fathiah S ; Kramski, Marit ; Angelovich, Thomas A ; Elliott, Julian ; Hearps, Anna Clare ; Price, Patricia ; Jaworowski, Anthony. / An NK cell population lacking FcRgamma is expanded in chronically infected HIV patients. In: Journal of Immunology. 2015 ; Vol. 194, No. 10. pp. 4688 - 4697.
@article{76deb3fef9d546df9ea006782b4b96f7,
title = "An NK cell population lacking FcRgamma is expanded in chronically infected HIV patients",
abstract = "We previously demonstrated that NK cells from HIV-infected individuals have elevated expression of activation markers, spontaneously degranulate ex vivo, and decrease expression of a signal-transducing protein for NK-activating receptors, FcR?. Importantly, these changes were maintained in virologically suppressed (VS) individuals receiving combination antiretroviral therapy (cART). In this study, we show that loss of FcR? is caused by the expansion of a novel subset of FcR?- CD56dim NK cells with an altered activation receptor repertoire and biological properties. In a cross-sectional study, FcR?- NK cells as a proportion of total CD56dim NK cells increased in cART-naive viremic HIV-infected individuals (median [interquartile range] = 25.9 [12.6- 56.1] compared with 3.80 [1.15-11.5] for HIV- controls, p <0.0001) and in VS HIV-infected individuals (22.7 [13.1-56.2] compared with 3.80 [1.15-11.5], p = 0.0004), with no difference between cART-naive and VS patients (p = 0.93). FcR?-NK cells expressed no NKp30 or NKp46. They showed greater Ab-dependent cellular cytotoxicity activity against rituximab-opsonized Raji cells and in a whole-blood assay measuring NK responses to overlapping HIV peptides, despite having reduced CD16 expression compared with conventional NK cells. Their prevalence correlated with CMV Ab titers in HIV- subjects but not in HIV,+ individuals, and with the inflammatory marker CXCL10 in both groups. The expansion of a subset of NK cells that lacks NKp30 and NKp46 to 90 of CD56dim NK cells in some VS HIV+ individuals may influence NK-mediated immunosurveillance in patients receiving cART. Copyright ? 2015 by The American Association of Immunologists, Inc.",
author = "Jingling Zhou and Amran, {Fathiah S} and Marit Kramski and Angelovich, {Thomas A} and Julian Elliott and Hearps, {Anna Clare} and Patricia Price and Anthony Jaworowski",
year = "2015",
doi = "10.4049/jimmunol.1402448",
language = "English",
volume = "194",
pages = "4688 -- 4697",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

An NK cell population lacking FcRgamma is expanded in chronically infected HIV patients. / Zhou, Jingling; Amran, Fathiah S; Kramski, Marit; Angelovich, Thomas A; Elliott, Julian; Hearps, Anna Clare; Price, Patricia; Jaworowski, Anthony.

In: Journal of Immunology, Vol. 194, No. 10, 2015, p. 4688 - 4697.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - An NK cell population lacking FcRgamma is expanded in chronically infected HIV patients

AU - Zhou, Jingling

AU - Amran, Fathiah S

AU - Kramski, Marit

AU - Angelovich, Thomas A

AU - Elliott, Julian

AU - Hearps, Anna Clare

AU - Price, Patricia

AU - Jaworowski, Anthony

PY - 2015

Y1 - 2015

N2 - We previously demonstrated that NK cells from HIV-infected individuals have elevated expression of activation markers, spontaneously degranulate ex vivo, and decrease expression of a signal-transducing protein for NK-activating receptors, FcR?. Importantly, these changes were maintained in virologically suppressed (VS) individuals receiving combination antiretroviral therapy (cART). In this study, we show that loss of FcR? is caused by the expansion of a novel subset of FcR?- CD56dim NK cells with an altered activation receptor repertoire and biological properties. In a cross-sectional study, FcR?- NK cells as a proportion of total CD56dim NK cells increased in cART-naive viremic HIV-infected individuals (median [interquartile range] = 25.9 [12.6- 56.1] compared with 3.80 [1.15-11.5] for HIV- controls, p <0.0001) and in VS HIV-infected individuals (22.7 [13.1-56.2] compared with 3.80 [1.15-11.5], p = 0.0004), with no difference between cART-naive and VS patients (p = 0.93). FcR?-NK cells expressed no NKp30 or NKp46. They showed greater Ab-dependent cellular cytotoxicity activity against rituximab-opsonized Raji cells and in a whole-blood assay measuring NK responses to overlapping HIV peptides, despite having reduced CD16 expression compared with conventional NK cells. Their prevalence correlated with CMV Ab titers in HIV- subjects but not in HIV,+ individuals, and with the inflammatory marker CXCL10 in both groups. The expansion of a subset of NK cells that lacks NKp30 and NKp46 to 90 of CD56dim NK cells in some VS HIV+ individuals may influence NK-mediated immunosurveillance in patients receiving cART. Copyright ? 2015 by The American Association of Immunologists, Inc.

AB - We previously demonstrated that NK cells from HIV-infected individuals have elevated expression of activation markers, spontaneously degranulate ex vivo, and decrease expression of a signal-transducing protein for NK-activating receptors, FcR?. Importantly, these changes were maintained in virologically suppressed (VS) individuals receiving combination antiretroviral therapy (cART). In this study, we show that loss of FcR? is caused by the expansion of a novel subset of FcR?- CD56dim NK cells with an altered activation receptor repertoire and biological properties. In a cross-sectional study, FcR?- NK cells as a proportion of total CD56dim NK cells increased in cART-naive viremic HIV-infected individuals (median [interquartile range] = 25.9 [12.6- 56.1] compared with 3.80 [1.15-11.5] for HIV- controls, p <0.0001) and in VS HIV-infected individuals (22.7 [13.1-56.2] compared with 3.80 [1.15-11.5], p = 0.0004), with no difference between cART-naive and VS patients (p = 0.93). FcR?-NK cells expressed no NKp30 or NKp46. They showed greater Ab-dependent cellular cytotoxicity activity against rituximab-opsonized Raji cells and in a whole-blood assay measuring NK responses to overlapping HIV peptides, despite having reduced CD16 expression compared with conventional NK cells. Their prevalence correlated with CMV Ab titers in HIV- subjects but not in HIV,+ individuals, and with the inflammatory marker CXCL10 in both groups. The expansion of a subset of NK cells that lacks NKp30 and NKp46 to 90 of CD56dim NK cells in some VS HIV+ individuals may influence NK-mediated immunosurveillance in patients receiving cART. Copyright ? 2015 by The American Association of Immunologists, Inc.

UR - http://www.jimmunol.org/content/194/10/4688.full.pdf+html

U2 - 10.4049/jimmunol.1402448

DO - 10.4049/jimmunol.1402448

M3 - Article

VL - 194

SP - 4688

EP - 4697

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -